Consumer DNA firms get serious about drug development

Erika Check Hayden

Nature, 2015, vol. 520, issue 7549, 597-598

Abstract: Companies race to gather large data sets in bid to find treatments based on genetics.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/520597a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:520:y:2015:i:7549:d:10.1038_520597a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/520597a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().